Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 References  














ML-SA1







Add links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


ML-SA1
Identifiers
  • 2-[2-oxo-2-(2,2,4-trimethyl-3,4-dihydroquinolin-1-yl)ethyl]isoindole-1,3-dione

CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC22H22N2O3
Molar mass362.429 g·mol−1
3D model (JSmol)
  • CC1CC(N(C2=CC=CC=C12)C(=O)CN3C(=O)C4=CC=CC=C4C3=O)(C)C

  • InChI=1S/C22H22N2O3/c1-14-12-22(2,3)24(18-11-7-6-8-15(14)18)19(25)13-23-20(26)16-9-4-5-10-17(16)21(23)27/h4-11,14H,12-13H2,1-3H3

  • Key:KDDHBJICVBONAX-UHFFFAOYSA-N

ML-SA1 is a chemical compound which acts as an "agonist" (i.e. channel opener) of the TRPML family of calcium channels. It has mainly been studied for its role in activating TRPML1 channels, although it also shows activity at the less studied TRPML2 and TRPML3 subtypes. TRPML1 is important for the function of lysosomes, and ML-SA1 has been used to study several disorders resulting from impaired lysosome function, including mucolipidosis type IV and Niemann-Pick's disease type C,[1][2][3][4] as well as other conditions such as stroke and Alzheimer's disease.[5][6]

References[edit]

  1. ^ Feng X, Xiong J, Lu Y, Xia X, Zhu MX (December 2014). "Differential mechanisms of action of the mucolipin synthetic agonist, ML-SA1, on insect TRPML and mammalian TRPML1". Cell Calcium. 56 (6): 446–56. doi:10.1016/j.ceca.2014.09.004. PMC 4252876. PMID 25266962.
  • ^ Erkhembaatar M, Gu DR, Lee SH, Yang YM, Park S, Muallem S, et al. (February 2017). "2+ Signaling is Essential for Osteoclastogenesis and Bone Remodeling". Journal of Bone and Mineral Research. 32 (2): 385–396. doi:10.1002/jbmr.2986. PMC 9850942. PMID 27589205.
  • ^ Gómez NM, Lu W, Lim JC, Kiselyov K, Campagno KE, Grishchuk Y, et al. (February 2018). "Robust lysosomal calcium signaling through channel TRPML1 is impaired by lysosomal lipid accumulation". FASEB Journal. 32 (2): 782–794. doi:10.1096/fj.201700220RR. PMC 5888396. PMID 29030399.
  • ^ Fine M, Schmiege P, Li X (October 2018). "2-mediated human TRPML1 regulation". Nature Communications. 9 (1): 4192. doi:10.1038/s41467-018-06493-7. PMC 6180102. PMID 30305615.
  • ^ Wang Y, Jiang SW, Liu X, Niu L, Ge XL, Zhang JC, et al. (2018). "Degradation of TRPML1 in Neurons Reduces Neuron Survival in Transient Global Cerebral Ischemia". Oxidative Medicine and Cellular Longevity. 2018: 4612727. doi:10.1155/2018/4612727. PMC 6312622. PMID 30662583.
  • ^ Hui L, Soliman ML, Geiger NH, Miller NM, Afghah Z, Lakpa KL, et al. (2019). "Acidifying Endolysosomes Prevented Low-Density Lipoprotein-Induced Amyloidogenesis". Journal of Alzheimer's Disease. 67 (1): 393–410. doi:10.3233/JAD-180941. PMC 6425476. PMID 30594929.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=ML-SA1&oldid=1216040745"

    Categories: 
    Phthalimides
    Amides
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Chemical pages without DrugBank identifier
    Articles without KEGG source
    Articles without UNII source
    Drugs missing an ATC code
    Drugs with no legal status
    Articles containing unverified chemical infoboxes
     



    This page was last edited on 28 March 2024, at 17:45 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki